Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

55 Scopus Citations
View graph of relations

Author(s)

  • W. F. Fong
  • C. Wang
  • G. Y. Zhu
  • C. H. Leung
  • H. Y. Cheung

Detail(s)

Original languageEnglish
Pages (from-to)160-165
Journal / PublicationPhytomedicine
Volume14
Issue number2-3
Publication statusPublished - 19 Feb 2007

Abstract

Prolonged chemotherapy may lead to the selective proliferation of multidrug resistant (MDR) cancer cells. In MDR HepG2-DR and K562-DR cells that over-expressed P-glycoprotein (Pgp), the extract of the rhizomes of Alisma orientalis (Sam) Juzep. showed a synergistic growth inhibitory effect with cancer drugs that are Pgp substrates including actinomycin D, puromycin, paclitaxel, vinblastine and doxorubicin. At the same toxicity levels the herbal extract was more effective than verapamil, a standard Pgp inhibitor, in enhancing cellular doxorubicin accumulation and preventing the efflux of rhodamin-123 from the MDR cells. The extract restored the effect of vinblastine on the induction of G2/M arrest in MDR cells. Our data suggest that A. orientalis may contain components that are effective inhibitors of Pgp. © 2006 Elsevier GmbH. All rights reserved.

Research Area(s)

  • HepG2-DR cells, K562-DR cells, Multidrug resistance, P-glycoprotein, Rhizoma Alismatis

Citation Format(s)

Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. / Fong, W. F.; Wang, C.; Zhu, G. Y. et al.
In: Phytomedicine, Vol. 14, No. 2-3, 19.02.2007, p. 160-165.

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review